HK Stock MarketDetailed Quotes

CHUNLI MEDICAL (01858)

Watchlist

16.000
-0.550-3.32%

Market Closed Jan 16 16:01 CST

6.14BMarket Cap21.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHUNLI MEDICAL (01858) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Turnover

48.75%756.09M

28.27%487.6M

3.60%229.84M

-33.32%805.86M

-35.84%508.28M

-29.70%380.13M

-9.95%221.85M

0.58%1.21B

4.24%792.16M

-5.37%540.71M

Operating income

48.75%756.09M

28.27%487.6M

3.60%229.84M

-33.32%805.86M

-35.84%508.28M

-29.70%380.13M

-9.95%221.85M

0.58%1.21B

4.24%792.16M

-5.37%540.71M

Operating expenses

-58.58%-247.45M

-48.25%-160.47M

-31.93%-76.57M

19.14%-268.95M

32.85%-156.04M

27.50%-108.25M

25.51%-58.04M

-15.47%-332.64M

-17.08%-232.37M

-2.55%-149.3M

Gross profit

44.40%508.64M

20.32%327.12M

-6.43%153.27M

-38.70%536.9M

-37.08%352.24M

-30.54%271.88M

-2.75%163.81M

-4.12%875.89M

-0.30%559.78M

-8.08%391.41M

Selling expenses

10.56%-146.2M

13.65%-96.27M

26.96%-46.12M

37.30%-240.25M

30.07%-163.46M

33.20%-111.48M

2.80%-63.15M

2.13%-383.14M

-1.56%-233.75M

-7.66%-166.89M

Administrative expenses

-23.11%-38.6M

-33.24%-28.39M

-120.50%-16.59M

-1.84%-45.29M

-8.46%-31.36M

-12.41%-21.31M

-6.69%-7.52M

-14.50%-44.47M

-17.15%-28.91M

-22.59%-18.96M

Research and development expenses

13.25%-86.47M

24.84%-50.85M

23.13%-26.9M

15.46%-133.1M

13.13%-99.68M

9.27%-67.66M

-5.17%-34.99M

3.02%-157.45M

-9.26%-114.74M

-3.16%-74.57M

Profit from asset sales

-90.19%3.85K

---15.72K

904.29%39.21K

7,237.14%39.21K

--39.21K

----

-84.57%3.9K

-102.17%-549.43

----

Revaluation surplus

16.44%7.08M

-8.01%4.3M

16.19%1.6M

-1.83%9.43M

-14.03%6.08M

6.57%4.67M

-31.73%1.38M

1.27%9.61M

8.14%7.07M

10.60%4.38M

-Changes in the fair value of other assets

16.44%7.08M

-8.01%4.3M

16.19%1.6M

-1.83%9.43M

-14.03%6.08M

6.57%4.67M

-31.73%1.38M

1.27%9.61M

8.14%7.07M

10.60%4.38M

Impairment and provision

-177.52%-45.71M

-256.79%-39.33M

-52.86%-8.37M

-51.72%-37.96M

-43.49%-16.47M

7.86%-11.02M

31.10%-5.48M

17.33%-25.02M

14.50%-11.48M

28.70%-11.96M

-Other impairment is provision

-177.52%-45.71M

-256.79%-39.33M

-52.86%-8.37M

-51.72%-37.96M

-43.49%-16.47M

7.86%-11.02M

31.10%-5.48M

17.33%-25.02M

14.50%-11.48M

28.70%-11.96M

Special items of operating profit

-40.39%10.13M

-31.79%8.52M

-10.33%5.4M

27.28%31.59M

11.86%16.99M

-11.25%12.5M

10.49%6.02M

13.14%24.82M

-47.15%15.19M

128.98%14.08M

Operating profit

246.10%202M

64.55%120.57M

3.57%60.32M

-60.73%113.65M

-68.86%58.37M

-45.10%73.27M

-4.75%58.24M

-6.26%289.39M

-12.73%187.42M

-20.96%133.47M

Financing cost

37.23%9.72M

-25.18%6.74M

284.31%4.17M

2.93%17.07M

-16.81%7.09M

80.47%9.01M

-9.55%1.08M

-17.81%16.58M

-48.62%8.52M

-13.57%4.99M

Adjustment items of earning before tax

-91.49%60.77K

-100.09%-699.16

-100.00%0.04

1,370.79%884.48K

1,530.27%713.98K

909.91%783.77K

819.68%839.1K

-100.87%-69.6K

97.78%-49.92K

103.46%77.61K

Earning before tax

220.09%211.79M

53.26%127.31M

7.18%64.49M

-56.98%131.6M

-66.22%66.16M

-40.04%83.07M

-3.31%60.16M

-9.19%305.91M

-14.49%195.88M

-19.64%138.54M

Tax

-291.32%-20.18M

-212.27%-12.83M

-27.66%-6.46M

75.30%-6.94M

66.53%-5.16M

67.26%-4.11M

20.53%-5.06M

3.68%-28.09M

20.47%-15.4M

18.57%-12.55M

After-tax profit from continuing operations

214.07%191.61M

44.98%114.48M

5.31%58.03M

-55.13%124.66M

-66.20%61.01M

-37.33%78.96M

-1.35%55.11M

-9.72%277.82M

-13.94%180.48M

-19.75%125.99M

Earning after tax

214.07%191.61M

44.98%114.48M

5.31%58.03M

-55.13%124.66M

-66.20%61.01M

-37.33%78.96M

-1.35%55.11M

-9.72%277.82M

-13.94%180.48M

-19.75%125.99M

Minority profit

156.74%81.02K

117.89%11.66K

56.20%-40.54K

-5,439.95%-326.73K

-0.29%-142.8K

29.05%-65.18K

---92.55K

---5.9K

---142.39K

---91.88K

Profit attributable to shareholders

213.21%191.53M

44.85%114.47M

5.20%58.07M

-55.01%124.99M

-66.14%61.15M

-37.32%79.03M

-1.18%55.2M

-9.72%277.82M

-13.87%180.62M

-19.69%126.08M

Basic earnings per share

212.50%0.5

42.86%0.3

7.14%0.15

-54.17%0.33

-65.96%0.16

-36.36%0.21

-6.67%0.14

-10.00%0.72

-14.55%0.47

-19.51%0.33

Diluted earnings per share

212.50%0.5

42.86%0.3

7.14%0.15

-54.17%0.33

-65.96%0.16

-36.36%0.21

-6.67%0.14

-10.00%0.72

-14.55%0.47

-19.51%0.33

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Turnover	48.75%756.09M	28.27%487.6M	3.60%229.84M	-33.32%805.86M	-35.84%508.28M	-29.70%380.13M	-9.95%221.85M	0.58%1.21B	4.24%792.16M	-5.37%540.71M
Operating income	48.75%756.09M	28.27%487.6M	3.60%229.84M	-33.32%805.86M	-35.84%508.28M	-29.70%380.13M	-9.95%221.85M	0.58%1.21B	4.24%792.16M	-5.37%540.71M
Operating expenses	-58.58%-247.45M	-48.25%-160.47M	-31.93%-76.57M	19.14%-268.95M	32.85%-156.04M	27.50%-108.25M	25.51%-58.04M	-15.47%-332.64M	-17.08%-232.37M	-2.55%-149.3M
Gross profit	44.40%508.64M	20.32%327.12M	-6.43%153.27M	-38.70%536.9M	-37.08%352.24M	-30.54%271.88M	-2.75%163.81M	-4.12%875.89M	-0.30%559.78M	-8.08%391.41M
Selling expenses	10.56%-146.2M	13.65%-96.27M	26.96%-46.12M	37.30%-240.25M	30.07%-163.46M	33.20%-111.48M	2.80%-63.15M	2.13%-383.14M	-1.56%-233.75M	-7.66%-166.89M
Administrative expenses	-23.11%-38.6M	-33.24%-28.39M	-120.50%-16.59M	-1.84%-45.29M	-8.46%-31.36M	-12.41%-21.31M	-6.69%-7.52M	-14.50%-44.47M	-17.15%-28.91M	-22.59%-18.96M
Research and development expenses	13.25%-86.47M	24.84%-50.85M	23.13%-26.9M	15.46%-133.1M	13.13%-99.68M	9.27%-67.66M	-5.17%-34.99M	3.02%-157.45M	-9.26%-114.74M	-3.16%-74.57M
Profit from asset sales	-90.19%3.85K	-90.19%3.85K	---15.72K	904.29%39.21K	7,237.14%39.21K	--39.21K	----	-84.57%3.9K	-102.17%-549.43	----
Revaluation surplus	16.44%7.08M	-8.01%4.3M	16.19%1.6M	-1.83%9.43M	-14.03%6.08M	6.57%4.67M	-31.73%1.38M	1.27%9.61M	8.14%7.07M	10.60%4.38M
-Changes in the fair value of other assets	16.44%7.08M	-8.01%4.3M	16.19%1.6M	-1.83%9.43M	-14.03%6.08M	6.57%4.67M	-31.73%1.38M	1.27%9.61M	8.14%7.07M	10.60%4.38M
Impairment and provision	-177.52%-45.71M	-256.79%-39.33M	-52.86%-8.37M	-51.72%-37.96M	-43.49%-16.47M	7.86%-11.02M	31.10%-5.48M	17.33%-25.02M	14.50%-11.48M	28.70%-11.96M
-Other impairment is provision	-177.52%-45.71M	-256.79%-39.33M	-52.86%-8.37M	-51.72%-37.96M	-43.49%-16.47M	7.86%-11.02M	31.10%-5.48M	17.33%-25.02M	14.50%-11.48M	28.70%-11.96M
Special items of operating profit	-40.39%10.13M	-31.79%8.52M	-10.33%5.4M	27.28%31.59M	11.86%16.99M	-11.25%12.5M	10.49%6.02M	13.14%24.82M	-47.15%15.19M	128.98%14.08M
Operating profit	246.10%202M	64.55%120.57M	3.57%60.32M	-60.73%113.65M	-68.86%58.37M	-45.10%73.27M	-4.75%58.24M	-6.26%289.39M	-12.73%187.42M	-20.96%133.47M
Financing cost	37.23%9.72M	-25.18%6.74M	284.31%4.17M	2.93%17.07M	-16.81%7.09M	80.47%9.01M	-9.55%1.08M	-17.81%16.58M	-48.62%8.52M	-13.57%4.99M
Adjustment items of earning before tax	-91.49%60.77K	-100.09%-699.16	-100.00%0.04	1,370.79%884.48K	1,530.27%713.98K	909.91%783.77K	819.68%839.1K	-100.87%-69.6K	97.78%-49.92K	103.46%77.61K
Earning before tax	220.09%211.79M	53.26%127.31M	7.18%64.49M	-56.98%131.6M	-66.22%66.16M	-40.04%83.07M	-3.31%60.16M	-9.19%305.91M	-14.49%195.88M	-19.64%138.54M
Tax	-291.32%-20.18M	-212.27%-12.83M	-27.66%-6.46M	75.30%-6.94M	66.53%-5.16M	67.26%-4.11M	20.53%-5.06M	3.68%-28.09M	20.47%-15.4M	18.57%-12.55M
After-tax profit from continuing operations	214.07%191.61M	44.98%114.48M	5.31%58.03M	-55.13%124.66M	-66.20%61.01M	-37.33%78.96M	-1.35%55.11M	-9.72%277.82M	-13.94%180.48M	-19.75%125.99M
Earning after tax	214.07%191.61M	44.98%114.48M	5.31%58.03M	-55.13%124.66M	-66.20%61.01M	-37.33%78.96M	-1.35%55.11M	-9.72%277.82M	-13.94%180.48M	-19.75%125.99M
Minority profit	156.74%81.02K	117.89%11.66K	56.20%-40.54K	-5,439.95%-326.73K	-0.29%-142.8K	29.05%-65.18K	---92.55K	---5.9K	---142.39K	---91.88K
Profit attributable to shareholders	213.21%191.53M	44.85%114.47M	5.20%58.07M	-55.01%124.99M	-66.14%61.15M	-37.32%79.03M	-1.18%55.2M	-9.72%277.82M	-13.87%180.62M	-19.69%126.08M
Basic earnings per share	212.50%0.5	42.86%0.3	7.14%0.15	-54.17%0.33	-65.96%0.16	-36.36%0.21	-6.67%0.14	-10.00%0.72	-14.55%0.47	-19.51%0.33
Diluted earnings per share	212.50%0.5	42.86%0.3	7.14%0.15	-54.17%0.33	-65.96%0.16	-36.36%0.21	-6.67%0.14	-10.00%0.72	-14.55%0.47	-19.51%0.33
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?